nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—NT5E—epilepsy syndrome	0.471	1	CbGaD
Pentoxifylline—ADORA1—Gabapentin—epilepsy syndrome	0.19	0.722	CbGbCtD
Pentoxifylline—CYP1A2—Carbamazepine—epilepsy syndrome	0.0148	0.0564	CbGbCtD
Pentoxifylline—CYP1A2—Primidone—epilepsy syndrome	0.0139	0.0526	CbGbCtD
Pentoxifylline—CYP1A2—Propofol—epilepsy syndrome	0.0124	0.0472	CbGbCtD
Pentoxifylline—CYP1A2—Phenobarbital—epilepsy syndrome	0.0119	0.0451	CbGbCtD
Pentoxifylline—CYP1A2—Diazepam—epilepsy syndrome	0.0112	0.0427	CbGbCtD
Pentoxifylline—CYP1A2—Valproic Acid—epilepsy syndrome	0.00886	0.0337	CbGbCtD
Pentoxifylline—ADORA2A—ganglion—epilepsy syndrome	0.00227	0.0691	CbGeAlD
Pentoxifylline—ADORA1—ganglion—epilepsy syndrome	0.00196	0.0597	CbGeAlD
Pentoxifylline—Caffeine—ATM—epilepsy syndrome	0.00141	0.835	CrCbGaD
Pentoxifylline—NT5E—telencephalon—epilepsy syndrome	0.00123	0.0374	CbGeAlD
Pentoxifylline—ADORA2A—forebrain—epilepsy syndrome	0.000951	0.029	CbGeAlD
Pentoxifylline—PDE4A—telencephalon—epilepsy syndrome	0.000937	0.0286	CbGeAlD
Pentoxifylline—NT5E—midbrain—epilepsy syndrome	0.000882	0.0269	CbGeAlD
Pentoxifylline—ADORA2A—telencephalon—epilepsy syndrome	0.000875	0.0267	CbGeAlD
Pentoxifylline—PDE5A—forebrain—epilepsy syndrome	0.000867	0.0264	CbGeAlD
Pentoxifylline—NT5E—spinal cord—epilepsy syndrome	0.00086	0.0262	CbGeAlD
Pentoxifylline—ADORA1—forebrain—epilepsy syndrome	0.000821	0.025	CbGeAlD
Pentoxifylline—PDE5A—telencephalon—epilepsy syndrome	0.000797	0.0243	CbGeAlD
Pentoxifylline—NT5E—head—epilepsy syndrome	0.000765	0.0233	CbGeAlD
Pentoxifylline—ADORA1—telencephalon—epilepsy syndrome	0.000755	0.023	CbGeAlD
Pentoxifylline—NT5E—nervous system—epilepsy syndrome	0.000725	0.0221	CbGeAlD
Pentoxifylline—NT5E—central nervous system—epilepsy syndrome	0.000698	0.0213	CbGeAlD
Pentoxifylline—ADORA2B—head—epilepsy syndrome	0.000655	0.0199	CbGeAlD
Pentoxifylline—ADORA2B—nervous system—epilepsy syndrome	0.000621	0.0189	CbGeAlD
Pentoxifylline—ADORA2A—spinal cord—epilepsy syndrome	0.000613	0.0187	CbGeAlD
Pentoxifylline—PDE4B—forebrain—epilepsy syndrome	0.000608	0.0185	CbGeAlD
Pentoxifylline—ADORA2B—central nervous system—epilepsy syndrome	0.000598	0.0182	CbGeAlD
Pentoxifylline—ADORA1—medulla oblongata—epilepsy syndrome	0.000594	0.0181	CbGeAlD
Pentoxifylline—ADORA2B—cerebellum—epilepsy syndrome	0.000584	0.0178	CbGeAlD
Pentoxifylline—PDE4B—telencephalon—epilepsy syndrome	0.000559	0.017	CbGeAlD
Pentoxifylline—NT5E—brain—epilepsy syndrome	0.000554	0.0169	CbGeAlD
Pentoxifylline—ADORA2A—head—epilepsy syndrome	0.000545	0.0166	CbGeAlD
Pentoxifylline—ADORA1—midbrain—epilepsy syndrome	0.000542	0.0165	CbGeAlD
Pentoxifylline—ADORA1—spinal cord—epilepsy syndrome	0.000529	0.0161	CbGeAlD
Pentoxifylline—PDE4A—cerebellum—epilepsy syndrome	0.000521	0.0159	CbGeAlD
Pentoxifylline—ADORA2A—nervous system—epilepsy syndrome	0.000516	0.0157	CbGeAlD
Pentoxifylline—ADORA2A—central nervous system—epilepsy syndrome	0.000497	0.0152	CbGeAlD
Pentoxifylline—PDE5A—head—epilepsy syndrome	0.000496	0.0151	CbGeAlD
Pentoxifylline—ADORA2A—cerebellum—epilepsy syndrome	0.000486	0.0148	CbGeAlD
Pentoxifylline—ADORA2B—brain—epilepsy syndrome	0.000474	0.0145	CbGeAlD
Pentoxifylline—PDE5A—nervous system—epilepsy syndrome	0.00047	0.0143	CbGeAlD
Pentoxifylline—ADORA1—head—epilepsy syndrome	0.00047	0.0143	CbGeAlD
Pentoxifylline—PDE5A—central nervous system—epilepsy syndrome	0.000453	0.0138	CbGeAlD
Pentoxifylline—ADORA1—nervous system—epilepsy syndrome	0.000446	0.0136	CbGeAlD
Pentoxifylline—PDE5A—cerebellum—epilepsy syndrome	0.000443	0.0135	CbGeAlD
Pentoxifylline—PDE4B—medulla oblongata—epilepsy syndrome	0.000439	0.0134	CbGeAlD
Pentoxifylline—ADORA1—central nervous system—epilepsy syndrome	0.000429	0.0131	CbGeAlD
Pentoxifylline—PDE4A—brain—epilepsy syndrome	0.000423	0.0129	CbGeAlD
Pentoxifylline—ADORA1—cerebellum—epilepsy syndrome	0.00042	0.0128	CbGeAlD
Pentoxifylline—PDE4B—midbrain—epilepsy syndrome	0.000401	0.0122	CbGeAlD
Pentoxifylline—ADORA2A—brain—epilepsy syndrome	0.000395	0.012	CbGeAlD
Pentoxifylline—PDE4B—spinal cord—epilepsy syndrome	0.000391	0.0119	CbGeAlD
Pentoxifylline—PDE5A—brain—epilepsy syndrome	0.00036	0.011	CbGeAlD
Pentoxifylline—PDE4B—head—epilepsy syndrome	0.000348	0.0106	CbGeAlD
Pentoxifylline—ADORA1—brain—epilepsy syndrome	0.000341	0.0104	CbGeAlD
Pentoxifylline—PDE4B—nervous system—epilepsy syndrome	0.00033	0.0101	CbGeAlD
Pentoxifylline—PDE4B—central nervous system—epilepsy syndrome	0.000318	0.00968	CbGeAlD
Pentoxifylline—PDE4B—cerebellum—epilepsy syndrome	0.00031	0.00946	CbGeAlD
Pentoxifylline—PDE4B—brain—epilepsy syndrome	0.000252	0.00768	CbGeAlD
Pentoxifylline—Caffeine—CYP2D6—epilepsy syndrome	0.000163	0.0965	CrCbGaD
Pentoxifylline—Caffeine—ABCB1—epilepsy syndrome	0.000117	0.0689	CrCbGaD
Pentoxifylline—Hepatitis—Topiramate—epilepsy syndrome	6.12e-05	0.000425	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Valproic Acid—epilepsy syndrome	6.1e-05	0.000424	CcSEcCtD
Pentoxifylline—Palpitations—Pregabalin—epilepsy syndrome	6.1e-05	0.000424	CcSEcCtD
Pentoxifylline—Asthenia—Phenytoin—epilepsy syndrome	6.1e-05	0.000423	CcSEcCtD
Pentoxifylline—Nausea—Midazolam—epilepsy syndrome	6.09e-05	0.000423	CcSEcCtD
Pentoxifylline—Muscle spasms—Gabapentin—epilepsy syndrome	6.08e-05	0.000423	CcSEcCtD
Pentoxifylline—Tachycardia—Valproic Acid—epilepsy syndrome	6.08e-05	0.000422	CcSEcCtD
Pentoxifylline—Diarrhoea—Zonisamide—epilepsy syndrome	6.07e-05	0.000422	CcSEcCtD
Pentoxifylline—Asthenia—Oxcarbazepine—epilepsy syndrome	6.06e-05	0.000421	CcSEcCtD
Pentoxifylline—Pruritus—Clonazepam—epilepsy syndrome	6.05e-05	0.00042	CcSEcCtD
Pentoxifylline—Vomiting—Vigabatrin—epilepsy syndrome	6.05e-05	0.00042	CcSEcCtD
Pentoxifylline—Skin disorder—Valproic Acid—epilepsy syndrome	6.05e-05	0.00042	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	6.02e-05	0.000418	CcSEcCtD
Pentoxifylline—Pruritus—Phenytoin—epilepsy syndrome	6.01e-05	0.000418	CcSEcCtD
Pentoxifylline—Nausea—Levetiracetam—epilepsy syndrome	6.01e-05	0.000417	CcSEcCtD
Pentoxifylline—Rash—Vigabatrin—epilepsy syndrome	6e-05	0.000417	CcSEcCtD
Pentoxifylline—Dizziness—Felbamate—epilepsy syndrome	6e-05	0.000416	CcSEcCtD
Pentoxifylline—Dermatitis—Vigabatrin—epilepsy syndrome	6e-05	0.000416	CcSEcCtD
Pentoxifylline—Pruritus—Oxcarbazepine—epilepsy syndrome	5.98e-05	0.000415	CcSEcCtD
Pentoxifylline—Convulsion—Pregabalin—epilepsy syndrome	5.98e-05	0.000415	CcSEcCtD
Pentoxifylline—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.98e-05	0.000415	CcSEcCtD
Pentoxifylline—Vision blurred—Gabapentin—epilepsy syndrome	5.96e-05	0.000414	CcSEcCtD
Pentoxifylline—Headache—Vigabatrin—epilepsy syndrome	5.96e-05	0.000414	CcSEcCtD
Pentoxifylline—Hypertension—Pregabalin—epilepsy syndrome	5.96e-05	0.000414	CcSEcCtD
Pentoxifylline—Vomiting—Diazepam—epilepsy syndrome	5.96e-05	0.000414	CcSEcCtD
Pentoxifylline—Anorexia—Valproic Acid—epilepsy syndrome	5.94e-05	0.000412	CcSEcCtD
Pentoxifylline—Tremor—Gabapentin—epilepsy syndrome	5.93e-05	0.000412	CcSEcCtD
Pentoxifylline—Rash—Diazepam—epilepsy syndrome	5.91e-05	0.00041	CcSEcCtD
Pentoxifylline—Dermatitis—Diazepam—epilepsy syndrome	5.9e-05	0.00041	CcSEcCtD
Pentoxifylline—Chest pain—Pregabalin—epilepsy syndrome	5.87e-05	0.000408	CcSEcCtD
Pentoxifylline—Myalgia—Pregabalin—epilepsy syndrome	5.87e-05	0.000408	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.87e-05	0.000408	CcSEcCtD
Pentoxifylline—Dizziness—Zonisamide—epilepsy syndrome	5.87e-05	0.000408	CcSEcCtD
Pentoxifylline—Headache—Diazepam—epilepsy syndrome	5.87e-05	0.000408	CcSEcCtD
Pentoxifylline—Anxiety—Pregabalin—epilepsy syndrome	5.85e-05	0.000407	CcSEcCtD
Pentoxifylline—Diarrhoea—Clonazepam—epilepsy syndrome	5.85e-05	0.000407	CcSEcCtD
Pentoxifylline—Anaemia—Gabapentin—epilepsy syndrome	5.85e-05	0.000406	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.83e-05	0.000405	CcSEcCtD
Pentoxifylline—Hypotension—Valproic Acid—epilepsy syndrome	5.82e-05	0.000404	CcSEcCtD
Pentoxifylline—Asthenia—Carbamazepine—epilepsy syndrome	5.82e-05	0.000404	CcSEcCtD
Pentoxifylline—Agitation—Gabapentin—epilepsy syndrome	5.82e-05	0.000404	CcSEcCtD
Pentoxifylline—Diarrhoea—Phenytoin—epilepsy syndrome	5.81e-05	0.000404	CcSEcCtD
Pentoxifylline—Discomfort—Pregabalin—epilepsy syndrome	5.8e-05	0.000403	CcSEcCtD
Pentoxifylline—Nausea—Fosphenytoin—epilepsy syndrome	5.8e-05	0.000403	CcSEcCtD
Pentoxifylline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	5.78e-05	0.000402	CcSEcCtD
Pentoxifylline—Angioedema—Gabapentin—epilepsy syndrome	5.78e-05	0.000402	CcSEcCtD
Pentoxifylline—Hypersensitivity—Lamotrigine—epilepsy syndrome	5.78e-05	0.000401	CcSEcCtD
Pentoxifylline—Vomiting—Felbamate—epilepsy syndrome	5.77e-05	0.0004	CcSEcCtD
Pentoxifylline—Dry mouth—Pregabalin—epilepsy syndrome	5.75e-05	0.000399	CcSEcCtD
Pentoxifylline—Pruritus—Carbamazepine—epilepsy syndrome	5.74e-05	0.000399	CcSEcCtD
Pentoxifylline—Rash—Felbamate—epilepsy syndrome	5.72e-05	0.000397	CcSEcCtD
Pentoxifylline—Dermatitis—Felbamate—epilepsy syndrome	5.71e-05	0.000397	CcSEcCtD
Pentoxifylline—Malaise—Gabapentin—epilepsy syndrome	5.71e-05	0.000396	CcSEcCtD
Pentoxifylline—Headache—Felbamate—epilepsy syndrome	5.68e-05	0.000395	CcSEcCtD
Pentoxifylline—Confusional state—Pregabalin—epilepsy syndrome	5.68e-05	0.000394	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	5.68e-05	0.000394	CcSEcCtD
Pentoxifylline—Flushing—Topiramate—epilepsy syndrome	5.68e-05	0.000394	CcSEcCtD
Pentoxifylline—Leukopenia—Gabapentin—epilepsy syndrome	5.66e-05	0.000393	CcSEcCtD
Pentoxifylline—Dizziness—Clonazepam—epilepsy syndrome	5.66e-05	0.000393	CcSEcCtD
Pentoxifylline—Nausea—Vigabatrin—epilepsy syndrome	5.65e-05	0.000393	CcSEcCtD
Pentoxifylline—Vomiting—Zonisamide—epilepsy syndrome	5.64e-05	0.000392	CcSEcCtD
Pentoxifylline—Insomnia—Valproic Acid—epilepsy syndrome	5.63e-05	0.000391	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Pregabalin—epilepsy syndrome	5.63e-05	0.000391	CcSEcCtD
Pentoxifylline—Oedema—Pregabalin—epilepsy syndrome	5.63e-05	0.000391	CcSEcCtD
Pentoxifylline—Asthenia—Lamotrigine—epilepsy syndrome	5.62e-05	0.000391	CcSEcCtD
Pentoxifylline—Dizziness—Phenytoin—epilepsy syndrome	5.62e-05	0.00039	CcSEcCtD
Pentoxifylline—Rash—Zonisamide—epilepsy syndrome	5.6e-05	0.000389	CcSEcCtD
Pentoxifylline—Infection—Pregabalin—epilepsy syndrome	5.6e-05	0.000389	CcSEcCtD
Pentoxifylline—Palpitations—Gabapentin—epilepsy syndrome	5.59e-05	0.000388	CcSEcCtD
Pentoxifylline—Dermatitis—Zonisamide—epilepsy syndrome	5.59e-05	0.000388	CcSEcCtD
Pentoxifylline—Dizziness—Oxcarbazepine—epilepsy syndrome	5.59e-05	0.000388	CcSEcCtD
Pentoxifylline—Nausea—Diazepam—epilepsy syndrome	5.57e-05	0.000387	CcSEcCtD
Pentoxifylline—Headache—Zonisamide—epilepsy syndrome	5.56e-05	0.000386	CcSEcCtD
Pentoxifylline—Dyspnoea—Valproic Acid—epilepsy syndrome	5.55e-05	0.000386	CcSEcCtD
Pentoxifylline—Diarrhoea—Carbamazepine—epilepsy syndrome	5.55e-05	0.000385	CcSEcCtD
Pentoxifylline—Pruritus—Lamotrigine—epilepsy syndrome	5.55e-05	0.000385	CcSEcCtD
Pentoxifylline—Shock—Pregabalin—epilepsy syndrome	5.54e-05	0.000385	CcSEcCtD
Pentoxifylline—Somnolence—Valproic Acid—epilepsy syndrome	5.54e-05	0.000385	CcSEcCtD
Pentoxifylline—Immune system disorder—Topiramate—epilepsy syndrome	5.52e-05	0.000384	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Pregabalin—epilepsy syndrome	5.51e-05	0.000383	CcSEcCtD
Pentoxifylline—Tachycardia—Pregabalin—epilepsy syndrome	5.5e-05	0.000382	CcSEcCtD
Pentoxifylline—Dyspepsia—Valproic Acid—epilepsy syndrome	5.48e-05	0.000381	CcSEcCtD
Pentoxifylline—Convulsion—Gabapentin—epilepsy syndrome	5.48e-05	0.000381	CcSEcCtD
Pentoxifylline—Skin disorder—Pregabalin—epilepsy syndrome	5.47e-05	0.00038	CcSEcCtD
Pentoxifylline—Hypertension—Gabapentin—epilepsy syndrome	5.46e-05	0.000379	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Pregabalin—epilepsy syndrome	5.44e-05	0.000378	CcSEcCtD
Pentoxifylline—Vomiting—Clonazepam—epilepsy syndrome	5.44e-05	0.000378	CcSEcCtD
Pentoxifylline—Decreased appetite—Valproic Acid—epilepsy syndrome	5.42e-05	0.000376	CcSEcCtD
Pentoxifylline—Vomiting—Phenytoin—epilepsy syndrome	5.4e-05	0.000375	CcSEcCtD
Pentoxifylline—Rash—Clonazepam—epilepsy syndrome	5.39e-05	0.000375	CcSEcCtD
Pentoxifylline—Dermatitis—Clonazepam—epilepsy syndrome	5.39e-05	0.000374	CcSEcCtD
Pentoxifylline—Chest pain—Gabapentin—epilepsy syndrome	5.39e-05	0.000374	CcSEcCtD
Pentoxifylline—Myalgia—Gabapentin—epilepsy syndrome	5.39e-05	0.000374	CcSEcCtD
Pentoxifylline—Nausea—Felbamate—epilepsy syndrome	5.39e-05	0.000374	CcSEcCtD
Pentoxifylline—Vomiting—Oxcarbazepine—epilepsy syndrome	5.37e-05	0.000373	CcSEcCtD
Pentoxifylline—Anxiety—Gabapentin—epilepsy syndrome	5.37e-05	0.000373	CcSEcCtD
Pentoxifylline—Anorexia—Pregabalin—epilepsy syndrome	5.37e-05	0.000373	CcSEcCtD
Pentoxifylline—Dizziness—Carbamazepine—epilepsy syndrome	5.36e-05	0.000373	CcSEcCtD
Pentoxifylline—Diarrhoea—Lamotrigine—epilepsy syndrome	5.36e-05	0.000373	CcSEcCtD
Pentoxifylline—Headache—Clonazepam—epilepsy syndrome	5.36e-05	0.000372	CcSEcCtD
Pentoxifylline—Rash—Phenytoin—epilepsy syndrome	5.36e-05	0.000372	CcSEcCtD
Pentoxifylline—Dermatitis—Phenytoin—epilepsy syndrome	5.35e-05	0.000372	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	5.35e-05	0.000372	CcSEcCtD
Pentoxifylline—Rash—Oxcarbazepine—epilepsy syndrome	5.33e-05	0.00037	CcSEcCtD
Pentoxifylline—Constipation—Valproic Acid—epilepsy syndrome	5.33e-05	0.00037	CcSEcCtD
Pentoxifylline—Dermatitis—Oxcarbazepine—epilepsy syndrome	5.32e-05	0.00037	CcSEcCtD
Pentoxifylline—Headache—Phenytoin—epilepsy syndrome	5.32e-05	0.00037	CcSEcCtD
Pentoxifylline—Erythema—Topiramate—epilepsy syndrome	5.32e-05	0.00037	CcSEcCtD
Pentoxifylline—Discomfort—Gabapentin—epilepsy syndrome	5.32e-05	0.00037	CcSEcCtD
Pentoxifylline—Headache—Oxcarbazepine—epilepsy syndrome	5.3e-05	0.000368	CcSEcCtD
Pentoxifylline—Nausea—Zonisamide—epilepsy syndrome	5.27e-05	0.000366	CcSEcCtD
Pentoxifylline—Dry mouth—Gabapentin—epilepsy syndrome	5.27e-05	0.000366	CcSEcCtD
Pentoxifylline—Hypotension—Pregabalin—epilepsy syndrome	5.26e-05	0.000365	CcSEcCtD
Pentoxifylline—Flatulence—Topiramate—epilepsy syndrome	5.25e-05	0.000364	CcSEcCtD
Pentoxifylline—Tension—Topiramate—epilepsy syndrome	5.22e-05	0.000363	CcSEcCtD
Pentoxifylline—Dysgeusia—Topiramate—epilepsy syndrome	5.21e-05	0.000362	CcSEcCtD
Pentoxifylline—Confusional state—Gabapentin—epilepsy syndrome	5.21e-05	0.000362	CcSEcCtD
Pentoxifylline—Dizziness—Lamotrigine—epilepsy syndrome	5.18e-05	0.00036	CcSEcCtD
Pentoxifylline—Nervousness—Topiramate—epilepsy syndrome	5.17e-05	0.000359	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.16e-05	0.000359	CcSEcCtD
Pentoxifylline—Oedema—Gabapentin—epilepsy syndrome	5.16e-05	0.000359	CcSEcCtD
Pentoxifylline—Vomiting—Carbamazepine—epilepsy syndrome	5.16e-05	0.000358	CcSEcCtD
Pentoxifylline—Back pain—Topiramate—epilepsy syndrome	5.15e-05	0.000358	CcSEcCtD
Pentoxifylline—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.13e-05	0.000357	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.13e-05	0.000356	CcSEcCtD
Pentoxifylline—Infection—Gabapentin—epilepsy syndrome	5.13e-05	0.000356	CcSEcCtD
Pentoxifylline—Muscle spasms—Topiramate—epilepsy syndrome	5.12e-05	0.000355	CcSEcCtD
Pentoxifylline—Rash—Carbamazepine—epilepsy syndrome	5.11e-05	0.000355	CcSEcCtD
Pentoxifylline—Dermatitis—Carbamazepine—epilepsy syndrome	5.11e-05	0.000355	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.09e-05	0.000354	CcSEcCtD
Pentoxifylline—Insomnia—Pregabalin—epilepsy syndrome	5.09e-05	0.000354	CcSEcCtD
Pentoxifylline—Nausea—Clonazepam—epilepsy syndrome	5.08e-05	0.000353	CcSEcCtD
Pentoxifylline—Headache—Carbamazepine—epilepsy syndrome	5.08e-05	0.000353	CcSEcCtD
Pentoxifylline—Shock—Gabapentin—epilepsy syndrome	5.08e-05	0.000353	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.06e-05	0.000351	CcSEcCtD
Pentoxifylline—Nausea—Phenytoin—epilepsy syndrome	5.05e-05	0.000351	CcSEcCtD
Pentoxifylline—Tachycardia—Gabapentin—epilepsy syndrome	5.04e-05	0.00035	CcSEcCtD
Pentoxifylline—Dyspnoea—Pregabalin—epilepsy syndrome	5.02e-05	0.000349	CcSEcCtD
Pentoxifylline—Nausea—Oxcarbazepine—epilepsy syndrome	5.02e-05	0.000349	CcSEcCtD
Pentoxifylline—Vision blurred—Topiramate—epilepsy syndrome	5.02e-05	0.000348	CcSEcCtD
Pentoxifylline—Skin disorder—Gabapentin—epilepsy syndrome	5.02e-05	0.000348	CcSEcCtD
Pentoxifylline—Somnolence—Pregabalin—epilepsy syndrome	5.01e-05	0.000348	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.99e-05	0.000347	CcSEcCtD
Pentoxifylline—Tremor—Topiramate—epilepsy syndrome	4.99e-05	0.000346	CcSEcCtD
Pentoxifylline—Vomiting—Lamotrigine—epilepsy syndrome	4.98e-05	0.000346	CcSEcCtD
Pentoxifylline—Urticaria—Valproic Acid—epilepsy syndrome	4.95e-05	0.000344	CcSEcCtD
Pentoxifylline—Rash—Lamotrigine—epilepsy syndrome	4.94e-05	0.000343	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Topiramate—epilepsy syndrome	4.94e-05	0.000343	CcSEcCtD
Pentoxifylline—Dermatitis—Lamotrigine—epilepsy syndrome	4.94e-05	0.000343	CcSEcCtD
Pentoxifylline—Abdominal pain—Valproic Acid—epilepsy syndrome	4.92e-05	0.000342	CcSEcCtD
Pentoxifylline—Body temperature increased—Valproic Acid—epilepsy syndrome	4.92e-05	0.000342	CcSEcCtD
Pentoxifylline—Anorexia—Gabapentin—epilepsy syndrome	4.92e-05	0.000342	CcSEcCtD
Pentoxifylline—Anaemia—Topiramate—epilepsy syndrome	4.92e-05	0.000342	CcSEcCtD
Pentoxifylline—Headache—Lamotrigine—epilepsy syndrome	4.91e-05	0.000341	CcSEcCtD
Pentoxifylline—Decreased appetite—Pregabalin—epilepsy syndrome	4.9e-05	0.00034	CcSEcCtD
Pentoxifylline—Agitation—Topiramate—epilepsy syndrome	4.89e-05	0.00034	CcSEcCtD
Pentoxifylline—Hypotension—Gabapentin—epilepsy syndrome	4.83e-05	0.000335	CcSEcCtD
Pentoxifylline—Nausea—Carbamazepine—epilepsy syndrome	4.82e-05	0.000335	CcSEcCtD
Pentoxifylline—Constipation—Pregabalin—epilepsy syndrome	4.82e-05	0.000334	CcSEcCtD
Pentoxifylline—Malaise—Topiramate—epilepsy syndrome	4.8e-05	0.000333	CcSEcCtD
Pentoxifylline—Leukopenia—Topiramate—epilepsy syndrome	4.77e-05	0.000331	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.71e-05	0.000327	CcSEcCtD
Pentoxifylline—Palpitations—Topiramate—epilepsy syndrome	4.7e-05	0.000327	CcSEcCtD
Pentoxifylline—Insomnia—Gabapentin—epilepsy syndrome	4.67e-05	0.000324	CcSEcCtD
Pentoxifylline—Nausea—Lamotrigine—epilepsy syndrome	4.66e-05	0.000323	CcSEcCtD
Pentoxifylline—Feeling abnormal—Pregabalin—epilepsy syndrome	4.64e-05	0.000322	CcSEcCtD
Pentoxifylline—Convulsion—Topiramate—epilepsy syndrome	4.61e-05	0.00032	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Pregabalin—epilepsy syndrome	4.61e-05	0.00032	CcSEcCtD
Pentoxifylline—Dyspnoea—Gabapentin—epilepsy syndrome	4.6e-05	0.00032	CcSEcCtD
Pentoxifylline—Hypertension—Topiramate—epilepsy syndrome	4.6e-05	0.000319	CcSEcCtD
Pentoxifylline—Somnolence—Gabapentin—epilepsy syndrome	4.59e-05	0.000319	CcSEcCtD
Pentoxifylline—Hypersensitivity—Valproic Acid—epilepsy syndrome	4.59e-05	0.000319	CcSEcCtD
Pentoxifylline—Dyspepsia—Gabapentin—epilepsy syndrome	4.55e-05	0.000316	CcSEcCtD
Pentoxifylline—Chest pain—Topiramate—epilepsy syndrome	4.53e-05	0.000315	CcSEcCtD
Pentoxifylline—Myalgia—Topiramate—epilepsy syndrome	4.53e-05	0.000315	CcSEcCtD
Pentoxifylline—Anxiety—Topiramate—epilepsy syndrome	4.52e-05	0.000314	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	4.5e-05	0.000313	CcSEcCtD
Pentoxifylline—Decreased appetite—Gabapentin—epilepsy syndrome	4.49e-05	0.000312	CcSEcCtD
Pentoxifylline—Discomfort—Topiramate—epilepsy syndrome	4.48e-05	0.000311	CcSEcCtD
Pentoxifylline—Urticaria—Pregabalin—epilepsy syndrome	4.47e-05	0.000311	CcSEcCtD
Pentoxifylline—Asthenia—Valproic Acid—epilepsy syndrome	4.47e-05	0.00031	CcSEcCtD
Pentoxifylline—Abdominal pain—Pregabalin—epilepsy syndrome	4.45e-05	0.000309	CcSEcCtD
Pentoxifylline—Body temperature increased—Pregabalin—epilepsy syndrome	4.45e-05	0.000309	CcSEcCtD
Pentoxifylline—Dry mouth—Topiramate—epilepsy syndrome	4.43e-05	0.000308	CcSEcCtD
Pentoxifylline—Constipation—Gabapentin—epilepsy syndrome	4.42e-05	0.000307	CcSEcCtD
Pentoxifylline—Pruritus—Valproic Acid—epilepsy syndrome	4.41e-05	0.000306	CcSEcCtD
Pentoxifylline—Confusional state—Topiramate—epilepsy syndrome	4.38e-05	0.000304	CcSEcCtD
Pentoxifylline—Oedema—Topiramate—epilepsy syndrome	4.34e-05	0.000302	CcSEcCtD
Pentoxifylline—Infection—Topiramate—epilepsy syndrome	4.32e-05	0.0003	CcSEcCtD
Pentoxifylline—Shock—Topiramate—epilepsy syndrome	4.27e-05	0.000297	CcSEcCtD
Pentoxifylline—Diarrhoea—Valproic Acid—epilepsy syndrome	4.26e-05	0.000296	CcSEcCtD
Pentoxifylline—Feeling abnormal—Gabapentin—epilepsy syndrome	4.26e-05	0.000296	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Topiramate—epilepsy syndrome	4.25e-05	0.000295	CcSEcCtD
Pentoxifylline—Tachycardia—Topiramate—epilepsy syndrome	4.24e-05	0.000294	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.22e-05	0.000293	CcSEcCtD
Pentoxifylline—Skin disorder—Topiramate—epilepsy syndrome	4.22e-05	0.000293	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Topiramate—epilepsy syndrome	4.2e-05	0.000292	CcSEcCtD
Pentoxifylline—Hypersensitivity—Pregabalin—epilepsy syndrome	4.15e-05	0.000288	CcSEcCtD
Pentoxifylline—Anorexia—Topiramate—epilepsy syndrome	4.14e-05	0.000288	CcSEcCtD
Pentoxifylline—Dizziness—Valproic Acid—epilepsy syndrome	4.12e-05	0.000286	CcSEcCtD
Pentoxifylline—Urticaria—Gabapentin—epilepsy syndrome	4.1e-05	0.000285	CcSEcCtD
Pentoxifylline—Body temperature increased—Gabapentin—epilepsy syndrome	4.08e-05	0.000284	CcSEcCtD
Pentoxifylline—Abdominal pain—Gabapentin—epilepsy syndrome	4.08e-05	0.000284	CcSEcCtD
Pentoxifylline—Hypotension—Topiramate—epilepsy syndrome	4.06e-05	0.000282	CcSEcCtD
Pentoxifylline—Asthenia—Pregabalin—epilepsy syndrome	4.04e-05	0.000281	CcSEcCtD
Pentoxifylline—Pruritus—Pregabalin—epilepsy syndrome	3.98e-05	0.000277	CcSEcCtD
Pentoxifylline—Vomiting—Valproic Acid—epilepsy syndrome	3.96e-05	0.000275	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.96e-05	0.000275	CcSEcCtD
Pentoxifylline—Insomnia—Topiramate—epilepsy syndrome	3.93e-05	0.000273	CcSEcCtD
Pentoxifylline—Rash—Valproic Acid—epilepsy syndrome	3.93e-05	0.000273	CcSEcCtD
Pentoxifylline—Dermatitis—Valproic Acid—epilepsy syndrome	3.92e-05	0.000273	CcSEcCtD
Pentoxifylline—Headache—Valproic Acid—epilepsy syndrome	3.9e-05	0.000271	CcSEcCtD
Pentoxifylline—Dyspnoea—Topiramate—epilepsy syndrome	3.87e-05	0.000269	CcSEcCtD
Pentoxifylline—Somnolence—Topiramate—epilepsy syndrome	3.86e-05	0.000268	CcSEcCtD
Pentoxifylline—Diarrhoea—Pregabalin—epilepsy syndrome	3.85e-05	0.000268	CcSEcCtD
Pentoxifylline—Dyspepsia—Topiramate—epilepsy syndrome	3.82e-05	0.000266	CcSEcCtD
Pentoxifylline—Hypersensitivity—Gabapentin—epilepsy syndrome	3.8e-05	0.000264	CcSEcCtD
Pentoxifylline—Decreased appetite—Topiramate—epilepsy syndrome	3.78e-05	0.000262	CcSEcCtD
Pentoxifylline—Dizziness—Pregabalin—epilepsy syndrome	3.72e-05	0.000259	CcSEcCtD
Pentoxifylline—Constipation—Topiramate—epilepsy syndrome	3.72e-05	0.000258	CcSEcCtD
Pentoxifylline—Asthenia—Gabapentin—epilepsy syndrome	3.71e-05	0.000257	CcSEcCtD
Pentoxifylline—Nausea—Valproic Acid—epilepsy syndrome	3.7e-05	0.000257	CcSEcCtD
Pentoxifylline—Pruritus—Gabapentin—epilepsy syndrome	3.65e-05	0.000254	CcSEcCtD
Pentoxifylline—Vomiting—Pregabalin—epilepsy syndrome	3.58e-05	0.000249	CcSEcCtD
Pentoxifylline—Feeling abnormal—Topiramate—epilepsy syndrome	3.58e-05	0.000249	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Topiramate—epilepsy syndrome	3.55e-05	0.000247	CcSEcCtD
Pentoxifylline—Rash—Pregabalin—epilepsy syndrome	3.55e-05	0.000247	CcSEcCtD
Pentoxifylline—Dermatitis—Pregabalin—epilepsy syndrome	3.55e-05	0.000246	CcSEcCtD
Pentoxifylline—Diarrhoea—Gabapentin—epilepsy syndrome	3.53e-05	0.000245	CcSEcCtD
Pentoxifylline—Headache—Pregabalin—epilepsy syndrome	3.53e-05	0.000245	CcSEcCtD
Pentoxifylline—Urticaria—Topiramate—epilepsy syndrome	3.45e-05	0.00024	CcSEcCtD
Pentoxifylline—Abdominal pain—Topiramate—epilepsy syndrome	3.43e-05	0.000239	CcSEcCtD
Pentoxifylline—Body temperature increased—Topiramate—epilepsy syndrome	3.43e-05	0.000239	CcSEcCtD
Pentoxifylline—Dizziness—Gabapentin—epilepsy syndrome	3.42e-05	0.000237	CcSEcCtD
Pentoxifylline—Nausea—Pregabalin—epilepsy syndrome	3.35e-05	0.000232	CcSEcCtD
Pentoxifylline—Vomiting—Gabapentin—epilepsy syndrome	3.28e-05	0.000228	CcSEcCtD
Pentoxifylline—Rash—Gabapentin—epilepsy syndrome	3.26e-05	0.000226	CcSEcCtD
Pentoxifylline—Dermatitis—Gabapentin—epilepsy syndrome	3.25e-05	0.000226	CcSEcCtD
Pentoxifylline—Headache—Gabapentin—epilepsy syndrome	3.24e-05	0.000225	CcSEcCtD
Pentoxifylline—Hypersensitivity—Topiramate—epilepsy syndrome	3.2e-05	0.000222	CcSEcCtD
Pentoxifylline—Asthenia—Topiramate—epilepsy syndrome	3.12e-05	0.000216	CcSEcCtD
Pentoxifylline—Pruritus—Topiramate—epilepsy syndrome	3.07e-05	0.000213	CcSEcCtD
Pentoxifylline—Nausea—Gabapentin—epilepsy syndrome	3.07e-05	0.000213	CcSEcCtD
Pentoxifylline—Diarrhoea—Topiramate—epilepsy syndrome	2.97e-05	0.000206	CcSEcCtD
Pentoxifylline—Dizziness—Topiramate—epilepsy syndrome	2.87e-05	0.0002	CcSEcCtD
Pentoxifylline—Vomiting—Topiramate—epilepsy syndrome	2.76e-05	0.000192	CcSEcCtD
Pentoxifylline—Rash—Topiramate—epilepsy syndrome	2.74e-05	0.00019	CcSEcCtD
Pentoxifylline—Dermatitis—Topiramate—epilepsy syndrome	2.74e-05	0.00019	CcSEcCtD
Pentoxifylline—Headache—Topiramate—epilepsy syndrome	2.72e-05	0.000189	CcSEcCtD
Pentoxifylline—Nausea—Topiramate—epilepsy syndrome	2.58e-05	0.000179	CcSEcCtD
Pentoxifylline—ADORA2A—Signaling Pathways—OXT—epilepsy syndrome	8.28e-06	9.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HSPB1—epilepsy syndrome	8.28e-06	9.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL2—epilepsy syndrome	8.28e-06	9.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—POMC—epilepsy syndrome	8.27e-06	9.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT3—epilepsy syndrome	8.23e-06	9.4e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—S100B—epilepsy syndrome	8.21e-06	9.38e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HES1—epilepsy syndrome	8.18e-06	9.34e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—POMC—epilepsy syndrome	8.17e-06	9.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCR5—epilepsy syndrome	8.17e-06	9.33e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SOCS3—epilepsy syndrome	8.13e-06	9.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADAM10—epilepsy syndrome	8.13e-06	9.29e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CDC42—epilepsy syndrome	8.11e-06	9.27e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CCL2—epilepsy syndrome	8.09e-06	9.24e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADAM10—epilepsy syndrome	8.04e-06	9.18e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CCL2—epilepsy syndrome	8e-06	9.14e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	8e-06	9.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FYN—epilepsy syndrome	7.95e-06	9.08e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—H2AFX—epilepsy syndrome	7.92e-06	9.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MEF2C—epilepsy syndrome	7.91e-06	9.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GAMT—epilepsy syndrome	7.9e-06	9.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NHLRC1—epilepsy syndrome	7.9e-06	9.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PNPO—epilepsy syndrome	7.9e-06	9.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—EPM2A—epilepsy syndrome	7.9e-06	9.03e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AVP—epilepsy syndrome	7.85e-06	8.97e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	7.72e-06	8.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC1—epilepsy syndrome	7.7e-06	8.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PTK2B—epilepsy syndrome	7.7e-06	8.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—S100B—epilepsy syndrome	7.69e-06	8.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	7.65e-06	8.73e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SOCS3—epilepsy syndrome	7.61e-06	8.7e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—S100B—epilepsy syndrome	7.6e-06	8.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CDC42—epilepsy syndrome	7.6e-06	8.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AGT—epilepsy syndrome	7.59e-06	8.67e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—NGF—epilepsy syndrome	7.56e-06	8.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SOCS3—epilepsy syndrome	7.52e-06	8.59e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CDC42—epilepsy syndrome	7.51e-06	8.57e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR2—epilepsy syndrome	7.49e-06	8.56e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NTRK2—epilepsy syndrome	7.49e-06	8.56e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SST—epilepsy syndrome	7.49e-06	8.56e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HES1—epilepsy syndrome	7.43e-06	8.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—DUSP6—epilepsy syndrome	7.43e-06	8.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AVP—epilepsy syndrome	7.35e-06	8.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCR5—epilepsy syndrome	7.35e-06	8.4e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CA4—epilepsy syndrome	7.35e-06	8.39e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—QDPR—epilepsy syndrome	7.35e-06	8.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRA2A—epilepsy syndrome	7.33e-06	8.37e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Biological oxidations—POMC—epilepsy syndrome	7.32e-06	8.36e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLAT—epilepsy syndrome	7.3e-06	8.34e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AVP—epilepsy syndrome	7.27e-06	8.3e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FYN—epilepsy syndrome	7.22e-06	8.25e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—HTR2A—epilepsy syndrome	7.2e-06	8.22e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—H2AFX—epilepsy syndrome	7.2e-06	8.22e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MEF2C—epilepsy syndrome	7.18e-06	8.2e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	7.04e-06	8.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL12—epilepsy syndrome	7.04e-06	8.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—AKT1—epilepsy syndrome	7.04e-06	8.04e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—POMC—epilepsy syndrome	7.03e-06	8.03e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	7.01e-06	8.01e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	6.98e-06	7.98e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HES1—epilepsy syndrome	6.95e-06	7.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—YWHAZ—epilepsy syndrome	6.94e-06	7.93e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUNB—epilepsy syndrome	6.91e-06	7.9e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CNR1—epilepsy syndrome	6.91e-06	7.9e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—COX3—epilepsy syndrome	6.91e-06	7.89e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PLCB1—epilepsy syndrome	6.89e-06	7.87e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HES1—epilepsy syndrome	6.87e-06	7.85e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—NGF—epilepsy syndrome	6.86e-06	7.84e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—TSC2—epilepsy syndrome	6.84e-06	7.81e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AGT—epilepsy syndrome	6.83e-06	7.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FYN—epilepsy syndrome	6.76e-06	7.72e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR7—epilepsy syndrome	6.75e-06	7.7e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—H2AFX—epilepsy syndrome	6.74e-06	7.7e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MEF2C—epilepsy syndrome	6.73e-06	7.68e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—APOE—epilepsy syndrome	6.69e-06	7.64e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FYN—epilepsy syndrome	6.68e-06	7.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCR5—epilepsy syndrome	6.68e-06	7.63e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—H2AFX—epilepsy syndrome	6.66e-06	7.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MEF2C—epilepsy syndrome	6.65e-06	7.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—KDR—epilepsy syndrome	6.55e-06	7.49e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HBEGF—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLCO1A2—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PFKL—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—KCNB1—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNA2D2—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC6A8—epilepsy syndrome	6.55e-06	7.48e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—HTR2A—epilepsy syndrome	6.54e-06	7.46e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—YWHAZ—epilepsy syndrome	6.5e-06	7.42e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT3—epilepsy syndrome	6.43e-06	7.34e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—NGF—epilepsy syndrome	6.43e-06	7.34e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—YWHAZ—epilepsy syndrome	6.42e-06	7.34e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.4e-06	7.31e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—POMC—epilepsy syndrome	6.39e-06	7.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.36e-06	7.26e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—NGF—epilepsy syndrome	6.35e-06	7.25e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PRKCB—epilepsy syndrome	6.31e-06	7.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—IL6ST—epilepsy syndrome	6.28e-06	7.18e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADAM10—epilepsy syndrome	6.28e-06	7.17e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCR5—epilepsy syndrome	6.25e-06	7.14e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CCL2—epilepsy syndrome	6.25e-06	7.14e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—TSC2—epilepsy syndrome	6.21e-06	7.09e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AGT—epilepsy syndrome	6.2e-06	7.08e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCR5—epilepsy syndrome	6.18e-06	7.06e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—HTR2A—epilepsy syndrome	6.12e-06	6.99e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—APOE—epilepsy syndrome	6.08e-06	6.94e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—HTR2A—epilepsy syndrome	6.05e-06	6.91e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—UPB1—epilepsy syndrome	5.99e-06	6.84e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NEU1—epilepsy syndrome	5.99e-06	6.84e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ATIC—epilepsy syndrome	5.99e-06	6.84e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—KDR—epilepsy syndrome	5.95e-06	6.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—S100B—epilepsy syndrome	5.94e-06	6.78e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SOCS3—epilepsy syndrome	5.88e-06	6.71e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CDC42—epilepsy syndrome	5.87e-06	6.7e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—TSC2—epilepsy syndrome	5.81e-06	6.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AGT—epilepsy syndrome	5.81e-06	6.63e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HSD17B4—epilepsy syndrome	5.76e-06	6.58e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—POMC—epilepsy syndrome	5.75e-06	6.56e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—TSC2—epilepsy syndrome	5.74e-06	6.56e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AGT—epilepsy syndrome	5.74e-06	6.55e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PRKCB—epilepsy syndrome	5.73e-06	6.54e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—IL6ST—epilepsy syndrome	5.71e-06	6.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—APOE—epilepsy syndrome	5.69e-06	6.5e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AVP—epilepsy syndrome	5.68e-06	6.48e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CCL2—epilepsy syndrome	5.62e-06	6.42e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—APOE—epilepsy syndrome	5.62e-06	6.42e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—KDR—epilepsy syndrome	5.57e-06	6.37e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PPP1R3C—epilepsy syndrome	5.57e-06	6.36e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GBE1—epilepsy syndrome	5.57e-06	6.36e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—KDR—epilepsy syndrome	5.51e-06	6.29e-05	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AKT1—epilepsy syndrome	5.45e-06	6.22e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.44e-06	6.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HES1—epilepsy syndrome	5.37e-06	6.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PRKCB—epilepsy syndrome	5.36e-06	6.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—IL6ST—epilepsy syndrome	5.34e-06	6.1e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PRKCB—epilepsy syndrome	5.3e-06	6.05e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—IL6ST—epilepsy syndrome	5.28e-06	6.03e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ASAH1—epilepsy syndrome	5.23e-06	5.98e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FYN—epilepsy syndrome	5.22e-06	5.96e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—POMC—epilepsy syndrome	5.22e-06	5.96e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—H2AFX—epilepsy syndrome	5.2e-06	5.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MEF2C—epilepsy syndrome	5.19e-06	5.93e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CCL2—epilepsy syndrome	5.11e-06	5.83e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—STXBP1—epilepsy syndrome	5.09e-06	5.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—FGF2—epilepsy syndrome	5.08e-06	5.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	5.02e-06	5.73e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—NGF—epilepsy syndrome	4.96e-06	5.67e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—NT5E—epilepsy syndrome	4.96e-06	5.67e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALAD—epilepsy syndrome	4.96e-06	5.67e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—POMC—epilepsy syndrome	4.89e-06	5.58e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—POMC—epilepsy syndrome	4.83e-06	5.52e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCR5—epilepsy syndrome	4.83e-06	5.51e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CCL2—epilepsy syndrome	4.78e-06	5.46e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNA1A—epilepsy syndrome	4.73e-06	5.41e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALDH7A1—epilepsy syndrome	4.73e-06	5.41e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CCL2—epilepsy syndrome	4.73e-06	5.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—HTR2A—epilepsy syndrome	4.72e-06	5.4e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RELA—epilepsy syndrome	4.72e-06	5.39e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ST3GAL3—epilepsy syndrome	4.63e-06	5.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MTOR—epilepsy syndrome	4.63e-06	5.28e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—FGF2—epilepsy syndrome	4.62e-06	5.27e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADSL—epilepsy syndrome	4.54e-06	5.18e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—TSC2—epilepsy syndrome	4.49e-06	5.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGT—epilepsy syndrome	4.48e-06	5.12e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GLUL—epilepsy syndrome	4.45e-06	5.08e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—APOE—epilepsy syndrome	4.39e-06	5.02e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CACNA1D—epilepsy syndrome	4.37e-06	4.99e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—FGF2—epilepsy syndrome	4.32e-06	4.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—KDR—epilepsy syndrome	4.3e-06	4.91e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	4.3e-06	4.91e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RELA—epilepsy syndrome	4.28e-06	4.89e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—FGF2—epilepsy syndrome	4.27e-06	4.88e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CASP3—epilepsy syndrome	4.26e-06	4.86e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MTOR—epilepsy syndrome	4.2e-06	4.8e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PRKCB—epilepsy syndrome	4.14e-06	4.73e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—JUN—epilepsy syndrome	4.13e-06	4.72e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—IL6ST—epilepsy syndrome	4.13e-06	4.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TXNRD1—epilepsy syndrome	4.09e-06	4.67e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—MMP9—epilepsy syndrome	4.02e-06	4.59e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RELA—epilepsy syndrome	4.01e-06	4.58e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AQP1—epilepsy syndrome	3.97e-06	4.53e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RELA—epilepsy syndrome	3.96e-06	4.53e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MTOR—epilepsy syndrome	3.93e-06	4.49e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AKT1—epilepsy syndrome	3.9e-06	4.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AKT1—epilepsy syndrome	3.9e-06	4.45e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MTOR—epilepsy syndrome	3.89e-06	4.44e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CASP3—epilepsy syndrome	3.86e-06	4.41e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.81e-06	4.35e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—POMC—epilepsy syndrome	3.77e-06	4.31e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—JUN—epilepsy syndrome	3.75e-06	4.29e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—SRC—epilepsy syndrome	3.71e-06	4.23e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CCL2—epilepsy syndrome	3.69e-06	4.22e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.65e-06	4.17e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—MMP9—epilepsy syndrome	3.65e-06	4.17e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CASP3—epilepsy syndrome	3.62e-06	4.13e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—VEGFA—epilepsy syndrome	3.61e-06	4.12e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AKT1—epilepsy syndrome	3.61e-06	4.12e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.59e-06	4.1e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.59e-06	4.1e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CASP3—epilepsy syndrome	3.58e-06	4.08e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AKT1—epilepsy syndrome	3.54e-06	4.05e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—JUN—epilepsy syndrome	3.51e-06	4.01e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—JUN—epilepsy syndrome	3.47e-06	3.97e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—MMP9—epilepsy syndrome	3.42e-06	3.91e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—MMP9—epilepsy syndrome	3.38e-06	3.86e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—SRC—epilepsy syndrome	3.37e-06	3.85e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.34e-06	3.82e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—FGF2—epilepsy syndrome	3.34e-06	3.81e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AKT1—epilepsy syndrome	3.32e-06	3.79e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—VEGFA—epilepsy syndrome	3.28e-06	3.75e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AKT1—epilepsy syndrome	3.28e-06	3.74e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.27e-06	3.74e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—SRC—epilepsy syndrome	3.15e-06	3.6e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—SRC—epilepsy syndrome	3.12e-06	3.56e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RELA—epilepsy syndrome	3.1e-06	3.54e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—VEGFA—epilepsy syndrome	3.07e-06	3.51e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MTOR—epilepsy syndrome	3.04e-06	3.47e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—VEGFA—epilepsy syndrome	3.03e-06	3.47e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.92e-06	3.34e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.85e-06	3.26e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.83e-06	3.24e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	2.82e-06	3.22e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.81e-06	3.21e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CASP3—epilepsy syndrome	2.79e-06	3.19e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—JUN—epilepsy syndrome	2.71e-06	3.1e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—MMP9—epilepsy syndrome	2.64e-06	3.02e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.56e-06	2.93e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AKT1—epilepsy syndrome	2.56e-06	2.92e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.56e-06	2.92e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—SRC—epilepsy syndrome	2.43e-06	2.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.43e-06	2.78e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.42e-06	2.77e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—VEGFA—epilepsy syndrome	2.37e-06	2.71e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.31e-06	2.64e-05	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AKT1—epilepsy syndrome	2.3e-06	2.63e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.29e-06	2.61e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TH—epilepsy syndrome	2.28e-06	2.6e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.24e-06	2.56e-05	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AKT1—epilepsy syndrome	2.09e-06	2.39e-05	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AKT1—epilepsy syndrome	1.96e-06	2.24e-05	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AKT1—epilepsy syndrome	1.94e-06	2.21e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.9e-06	2.17e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.88e-06	2.14e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.83e-06	2.08e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.7e-06	1.94e-05	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AKT1—epilepsy syndrome	1.51e-06	1.73e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.49e-06	1.7e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.46e-06	1.67e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.25e-06	1.43e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.14e-06	1.3e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.99e-07	1.14e-05	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AKT1—epilepsy syndrome	5.02e-07	5.73e-06	CbGpPWpGaD
